Sub Banner Image

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug

Market Impact

Vandana Singh

·

July 9, 2025

·

Benzinga

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.